Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Magenta Therapeutics, Inc. (MGTA)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Magenta Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Magenta Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is MGTA. The reporting company's CIK number is 1690585.
The total value of stock buying since 2005 is $105,000.
The total value of stock sales since 2005 is $1,304,200.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-01||Cooke Michael P. (Chief Scientific Officer)||Sale||5,000||10.67||53,335|
|2019-10-01||Cooke Michael P. (Chief Scientific Officer)||Sale||5,000||10.01||50,065|
|2019-09-19||Cooke Michael P. (Chief Scientific Officer)||Sale||1,656||12.00||19,872|
|2019-09-12||Cooke Michael P. (Chief Scientific Officer)||Sale||844||12.00||10,128|
|2019-09-03||Cooke Michael P. (Chief Scientific Officer)||Sale||5,000||10.11||50,530|
|2019-08-01||Cooke Michael P. (Chief Scientific Officer)||Sale||7,500||13.41||100,612|
|2019-07-01||Cooke Michael P. (Chief Scientific Officer)||Sale||7,500||14.40||108,022|
|2019-06-21||Gardner Jason (See Remarks)||Sale||12,331||15.11||186,321|
|2019-06-21||Isacson Christina K. (Chief Business Officer)||Sale||5,415||16.07||87,019|
|2019-06-20||Gardner Jason (See Remarks)||Sale||1,669||15.10||25,201|
|2019-06-17||Cooke Michael P. (Chief Scientific Officer)||Sale||7,500||13.90||104,265|
|2019-03-20||Atlas Venture Associates X, Llc (10% Owner)||Sale||14,245||17.86||254,415|
|2019-03-20||Booth Bruce (Director)||Sale||14,245||17.86||254,415|
|2018-06-25||Gardner Jason (See Remarks)||Buy||400||15.00||6,000|
|2018-06-25||Scadden David (Director)||Buy||6,600||15.00||99,000|
Insider trading activities including stock purchases, stock sales, and option exercises of MGTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Magenta Therapeutics, Inc. (symbol MGTA, CIK number 1690585) see the Securities and Exchange Commission (SEC) website.